Fig. 2From: Prospective evaluation of intravitreal bevacizumab for ischemic central retinal vein occlusionChange in retinal thickness after intravitreal bevacizumab. A 48-year-old patient presented with intraretinal hemorrhages in the four quadrants ischemic, macular edema, vascular tortuosity compatible with central retinal vein occlusion, which is shown by fluorescein angiography (a, b). He had symptoms for 2 months. Baseline visual acuity was reduced to 20/200, and the baseline optical coherence tomography shows macular edema and serous retinal detachment (c). At the 6-month follow-up macular edema has decreased, the foveal contour has been recovered, and there is degeneration of the outer retinal layersBack to article page